These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9872327)

  • 1. A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability.
    Shen SX; Weaver Z; Xu X; Li C; Weinstein M; Chen L; Guan XY; Ried T; Deng CX
    Oncogene; 1998 Dec; 17(24):3115-24. PubMed ID: 9872327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice.
    Brodie SG; Xu X; Qiao W; Li WM; Cao L; Deng CX
    Oncogene; 2001 Nov; 20(51):7514-23. PubMed ID: 11709723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumor formation in p53- and BRCA1-deficient mice.
    Cressman VL; Backlund DC; Hicks EM; Gowen LC; Godfrey V; Koller BH
    Cell Growth Differ; 1999 Jan; 10(1):1-10. PubMed ID: 9950212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
    Buller RE; Lallas TA; Shahin MS; Sood AK; Hatterman-Zogg M; Anderson B; Sorosky JI; Kirby PA
    Clin Cancer Res; 2001 Apr; 7(4):831-8. PubMed ID: 11309330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX; Scott F
    Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brca1 heterozygous mice have shortened life span and are prone to ovarian tumorigenesis with haploinsufficiency upon ionizing irradiation.
    Jeng YM; Cai-Ng S; Li A; Furuta S; Chew H; Chen PL; Lee EY; Lee WH
    Oncogene; 2007 Sep; 26(42):6160-6. PubMed ID: 17420720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells.
    Fedier A; Steiner RA; Schwarz VA; Lenherr L; Haller U; Fink D
    Int J Oncol; 2003 May; 22(5):1169-73. PubMed ID: 12684687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX
    Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
    Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
    Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned from BRCA1 and BRCA2.
    Zheng L; Li S; Boyer TG; Lee WH
    Oncogene; 2000 Dec; 19(53):6159-75. PubMed ID: 11156530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
    Reedy MB; Hang T; Gallion H; Arnold S; Smith SA
    Gynecol Oncol; 2001 Jun; 81(3):441-6. PubMed ID: 11371136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaboration of Brca1 and Chk2 in tumorigenesis.
    McPherson JP; Lemmers B; Hirao A; Hakem A; Abraham J; Migon E; Matysiak-Zablocki E; Tamblyn L; Sanchez-Sweatman O; Khokha R; Squire J; Hande MP; Mak TW; Hakem R
    Genes Dev; 2004 May; 18(10):1144-53. PubMed ID: 15131084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint.
    Wang RH; Yu H; Deng CX
    Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17108-13. PubMed ID: 15563594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
    Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
    Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.